Comparative Effectiveness Review: Benefits and Harms of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications

BACKGROUND: Recombinant Factor VIIa (rFVIIa), a hemostatic agent approved for hemophilia, is increasingly used for off-label indications. PURPOSE: To evaluate benefits and harms of rFVIIa use for five off-label, in-hospital indications: intracranial hemorrhage, cardiac surgery, trauma, liver transpl...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Yank, Veronica, Tuohy, C. Vaughan, Logan, Aaron C., Bravata, Dena M., Staudenmayer, Kristan, Eisenhut, Robin, Sundaram, Vandana, McMahon, Donal, Olkin, Ingram, McDonald, Kathryn M., Owens, Douglas K., Stafford, Randall S.
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4102260/
https://ncbi.nlm.nih.gov/pubmed/21502651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/0003-4819-154-8-201104190-00004
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items